Arun Jayant Sanyal

Institution information unavailable

Research Areas

Discover Papers by Arun Jayant Sanyal

Access 250+ million papers and cite this researcher's work with AI assistance

Try AnswerThis Free →

H-index

177

Publications

1839

Citations

164328

i10-index

793

Publications & Citations Over Time

Top Cited Publications

Want to find and read papers by this researcher? AnswerThis gives you instant access.

Title	Year	Citations
Design and validation of a histological scoring sy...	2005	10792
The diagnosis and management of nonalcoholic fatty...	2017	7234
Mechanisms of NAFLD development and therapeutic st...	2018	4295
The diagnosis and management of non-alcoholic fatt...	2012	3804
Pioglitazone, Vitamin E, or Placebo for Nonalcohol...	2010	3325
MAFLD: A Consensus-Driven Proposed Nomenclature fo...	2020	3279
A multisociety Delphi consensus statement on new f...	2023	3201
A multisociety Delphi consensus statement on new f...	2023	3038
Modeling the epidemic of nonalcoholic fatty liver ...	2017	2406
Farnesoid X nuclear receptor ligand obeticholic ac...	2014	2231

Publications

1.
Design and validation of a histological scoring system for nonalcoholic fatty liver disease†
Year: 2005Citations: 10792DOI: 10.1002/hep.20701
2.
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
Year: 2017Citations: 7234DOI: 10.1002/hep.29367
3.
Mechanisms of NAFLD development and therapeutic strategies
Year: 2018Citations: 4295DOI: 10.1038/s41591-018-0104-9
4.
The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
Year: 2012Citations: 3804DOI: 10.1002/hep.25762
5.
Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
Year: 2010Citations: 3325DOI: 10.1056/nejmoa0907929
6.
MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease
Year: 2020Citations: 3279DOI: 10.1053/j.gastro.2019.11.312
7.
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
Year: 2023Citations: 3201DOI: 10.1097/hep.0000000000000520
8.
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
Year: 2023Citations: 3038DOI: 10.1016/j.jhep.2023.06.003
9.
Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease
Year: 2017Citations: 2406DOI: 10.1002/hep.29466
10.
Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
Year: 2014Citations: 2231DOI: 10.1016/s0140-6736(14)61933-4

About Arun Jayant Sanyal

Arun Jayant Sanyal is a researcher with 1839 publications and 164328 citations. Their research focuses on . With an h-index of 177, they are among the top researchers in their field.

Citation Distribution

Distribution of citations across publications

Research Smarter

AnswerThis uses AI to help you search, understand, and cite research from Arun Jayant Sanyal and 250M+ other papers.

AI-powered research assistance
Automatic citations and references
Advanced academic writing tools

Research Area Breakdown

Publication Types

Publication type data not available

Impact Metrics Over Time

Citations per publication by year